:

US EXPANDS CHINA TECH RESTRICTIONS TO ROBOTS, POWER GEAR

INDUSTRY DESK1 MIN READ
WED, JUL 29, 2026

■ AI-SUMMARIZED FROM 2 SOURCES ▸ TIMELINE

The US is broadening trade restrictions on Chinese technology, now targeting humanoid robots and power inverters. The move escalates the ongoing tech confrontation between Washington and Beijing.

The US plans to restrict imports of additional foreign-made goods as part of its escalating tech clash with China. The new restrictions cover humanoid robots and power inverters—components critical to renewable energy infrastructure and emerging automation sectors. These curbs represent a widening of existing US trade policies that have previously targeted semiconductors, manufacturing equipment, and other advanced technologies. Power inverters are essential for solar and wind energy systems, while humanoid robots are increasingly used in manufacturing and logistics. The restrictions signal Washington's intent to limit China's access to advanced technology markets and protect US domestic manufacturers. Beijing has not yet responded formally to the proposed measures. The escalation comes as US-China technology competition intensifies across multiple sectors, from artificial intelligence to renewable energy. Both countries have implemented various trade barriers and export controls in recent months, deepening the rift in the global tech supply chain.

■ SOURCES

Bloomberg TechBloomberg Tech

■ SUMMARY WRITTEN BY AI FROM THE LINKS ABOVE

■ MORE FROM THE BUSINESS DESK

Matt McLennan, head of First Eagle Investments' Global Value Team, warns that excessive market focus on artificial intelligence has created dangerous complacency among investors.

JUST NOWAI Desk

Flipkart's payments app Super.money is expanding into e-commerce, enabling users to purchase items through interest-free installment plans. The move broadens the company's fintech offerings beyond payments.

JUST NOWIndustry Desk

The FDA has approved Moderna's mFLUSIVA, an mRNA-based flu vaccine for adults 50 and older. The approval marks the first seasonal flu vaccine using messenger RNA technology.

1H AGOIndustry Desk

Alphabet's $25 billion bond offering drew $115 billion in orders, signaling strong investor appetite for AI-linked debt after recent market volatility. The oversubscription highlights renewed confidence in tech sector financing.

1H AGOAI Desk

■ SUBSCRIBE TO THE DAILY BRIEF

ONE EMAIL, 5 STORIES, 06:00 UTC. UNSUBSCRIBE ANYTIME.